James Surek
CEO

This company develops a coin-sized, fully-implanted neurostimulator that delivers automatic stimulation to peripheral nerves. Their device targets nerves like the tibial nerve to treat chronic conditions such as urge urinary incontinence, potentially reducing the risk of cardiovascular disease and stroke.
Funding not disclosed

CEO